Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy

Stopped early · Phase 4

Conditions studied: Lumbar Herniated Disc

In brief

To compare the outcomes of percutaneous lumbar Hydrodiscectomy (HydroD) with the SpineJet Hydrodiscectomy System to transforaminal epidural steroid injections (TESI) in patients with lumbar radiculopathy due to contained disc herniation with symptoms that persist following a treatment course of conservative management including physical therapy and anti-inflammatory medication.

Key facts

Study ID
NCT02414698
Run by
Montefiore Medical Center
People needed
4
Starts
2015-01-01
Expected to finish
2015-03-01
Last updated by the study team
2020-03-02

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.